Advances in SARS-CoV-2 Infection and Variants
A special issue of Microorganisms (ISSN 2076-2607). This special issue belongs to the section "Virology".
Deadline for manuscript submissions: closed (15 February 2023) | Viewed by 38086
Special Issue Editor
Interests: COVID-19; molecular and genomic genotyping; reinfection; vaccination; infective endocarditis medical microbiology; infectious diseases; antibiotic resistance
Special Issue Information
Dear Colleagues,
Since 2020, the Coronavirus Disease 2019 (COVID-19) pandemic has been spreading worldwide, causing health, social, and economic distress. This infectious disease is caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which is an RNA, constantly evolving, virus. The emergence of variants over time is therefore an expected phenomenon and can have an impact on the dynamics of the epidemic or the effectiveness of preventive measures including screening tests, vaccines and therapeutic molecules.
Molecular and genomic surveillance of SARS-CoV-2 variants is now one of the pillars of the fight against COVID-19 on a global scale. The aim of this Special Issue is to ultimately identify the share of the different variants circulating in different countries worldwide in order to describe and monitor their circulation and their evolution over time, whatever the clinical indication (clusters of infected people, reinfection, persistence, infection following vaccination, etc).
SARS-CoV-2 variants are currently classified as variants of interest (VOI) or variants of concern (VOC). A variant is considered a VOI when it has mutations that are suspected or known to cause significant changes and it is circulating widely. The World Health Organization continuously monitors the VOIs in case they spread more easily, cause more severe disease, escape the body’s immune response regarding natural defense mechanisms or vaccines, change clinical presentation with increased transmissibility, infectivity, severity of infection, or decrease effectiveness of known tools, such as public health measures, diagnostics, treatments and vaccines. Several VOCs have been detected, including the Alpha variant (B.1.1.7) first identified in the UK, Beta variant (B.1.351) in South Africa, Gamma variant (P.1/B.1.1.28.1) in Brazil, Delta variant (B.1.617.2) in India and more recently the Omicron variant (B.1.1.529) in South Africa in November 2021.
From this perspective, we are pleased to invite you to present submissions on the topic, “Advances in SARS-CoV-2 Infection and Variants“, which deserves a Special Issue in Microorganisms. Original research articles and reviews are welcome.
We look forward to receiving your contributions.
Dr. Linda Houhamdi
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- SARS-CoV-2
- COVID-19
- variant of concern (VOC)
- variant of interest (VOI)
- genomic genotyping
- phylogeny
- molecular genotyping
- screening
- GISAID (Global Initiative on Sharing Avians Influenza Data)
- Pangolin (Phylogenetic Assignment of Named Outbeak LINeages)
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.